MCB4271 EXAM 3 QUESTIONS WITH CORRECT
ANSWERS
According |to |WHO, |what |is |the |purpose |of |surveillance? |- |CORRECT |ANSWER✔✔-"To |better |
understand |and |respond |to |antimicrobial |resistance |patterns |and |key |drivers, |information |
about |antimicrobial |resistance |incidence, |prevalence, |and |trends"
What |is |the |purpose |of |surveillance |on |AMR? |- |CORRECT |ANSWER✔✔--To |determine |the |
scope |of |the |problem
-Formulate |effective |response |to |AMR
-Monitor |effectiveness |of |the |response |to |AMR
What |are |the |general |conclusions |on |the |surveillance |on |AMR? |- |CORRECT |ANSWER✔✔--too |
many |gaps |in |info |on |pathogens |of |major |public |conern
-surveillance |is |not |coordinated/harmonized
-many |common |treatments |for |bacterial |infex |are |becoming |ineffective |across |the |world
-ABR |has |negative |impact |on |outcomes |for |affected |patients |and |healthcare |expenditures
-high |levels |of |resistance |have |been |observed |in |bacteria |that |cause |common |HAI/CAI |across |
all |WHO |regions
-use |TB, |malaria, |HIV |as |a |model
What |is |GLASS? |- |CORRECT |ANSWER✔✔-Global |Antimicrobial |Resistance |Surveillance |System
What |is |the |goal |of |GLASS? |- |CORRECT |ANSWER✔✔-"to |enable |standardized, |comparable, |and
|validated |data |on |AMR |to |be |collected, |analysed |and |shared |with |countries, |in |order |to |
inform |decision-making, |drive |local, |national |and |regional |action |and |provide |the |evidence |
based |for |action |and |advocacy."
ANSWERS
According |to |WHO, |what |is |the |purpose |of |surveillance? |- |CORRECT |ANSWER✔✔-"To |better |
understand |and |respond |to |antimicrobial |resistance |patterns |and |key |drivers, |information |
about |antimicrobial |resistance |incidence, |prevalence, |and |trends"
What |is |the |purpose |of |surveillance |on |AMR? |- |CORRECT |ANSWER✔✔--To |determine |the |
scope |of |the |problem
-Formulate |effective |response |to |AMR
-Monitor |effectiveness |of |the |response |to |AMR
What |are |the |general |conclusions |on |the |surveillance |on |AMR? |- |CORRECT |ANSWER✔✔--too |
many |gaps |in |info |on |pathogens |of |major |public |conern
-surveillance |is |not |coordinated/harmonized
-many |common |treatments |for |bacterial |infex |are |becoming |ineffective |across |the |world
-ABR |has |negative |impact |on |outcomes |for |affected |patients |and |healthcare |expenditures
-high |levels |of |resistance |have |been |observed |in |bacteria |that |cause |common |HAI/CAI |across |
all |WHO |regions
-use |TB, |malaria, |HIV |as |a |model
What |is |GLASS? |- |CORRECT |ANSWER✔✔-Global |Antimicrobial |Resistance |Surveillance |System
What |is |the |goal |of |GLASS? |- |CORRECT |ANSWER✔✔-"to |enable |standardized, |comparable, |and
|validated |data |on |AMR |to |be |collected, |analysed |and |shared |with |countries, |in |order |to |
inform |decision-making, |drive |local, |national |and |regional |action |and |provide |the |evidence |
based |for |action |and |advocacy."
